The latest headlines across every section, pulled from official and open-access sources.
This cohort study investigates associations between federal housing assistance, receipt of guideline-concordant treatment, and survival among Medicare beneficiaries with non–small cell lung cancer (NSCLC).
This cohort study assesses the variation in measles-containing vaccine coverage at the county census tract level among children aged 7 years in Northern California.
This cross-sectional study investigates the experience of clinical constraints related to state abortion laws and its association with moral distress among obstetrician-gynecologists.
This cohort study estimates lifetime incidence of breast and ovarian cancer among females undergoing BRCA1 or BRCA2 testing across all result categories and evaluates the modifying association of family history.
This qualitative study investigates how individuals traveling from states with restrictions on abortion provision perceive remote medication abortion and identifies factors affecting their care decisions.
This cohort study evaluates whether fat mass percentage and other body-composition measures are associated with risk of fracture among postmenopausal women with early breast cancer receiving aromatase inhibitor (AI) therapy.
Doctronic acquired Summer Health to expand into pediatric care and strengthen its AI-powered primary care platform. The post Doctronic Acquires Summer Health to Expand into Pediatric Primary Care appeared first on MedCity News .
With the merger, Processa’s new lead asset is a Vidya Therapeutics immunology drug that offers pipeline-in-a-product potential addressing a target that has clinical and regulatory validation from a recently approved Novartis drug. Vidya’s molecule is a next-generation drug that could have advantages over Novartis’s pill. The post Processa Acquisition Lands Immunology Drug That Could Rival a New Novartis Product appeared first on MedCity News .
A survey of 112 health system executives finds that Epic’s hold on hospital IT keeps getting stronger — but startups still have a shot, provided they solve a specific problem, prove strong ROI or offer a product that Epic is lagging behind on. The post Epic-First Doesn’t Mean Epic-Only: Where Hospitals Are Still Buying from Startups appeared first on MedCity News .
Patients should still be warned that general-purpose chatbots are often unreliable for medical advice.
Three studies using National Health and Nutrition Examination Survey (NHANES) data published July 20 in JAMA provide new insights into LDL-C treatment goals under the 2026 ACC/AHA Guideline on the Management of Dyslipidemia.
Drug Trials Snapshots: DECNUPAZ
FDA today licensed Ezplaz Freeze Dried Plasma (FDP), making it the first freeze-dried plasma product licensed for use in the United States. Ezplaz is intended for transfusion in adult patients who need plasma and for whom other plasma products are not available.
Challenges in the electrophysiology and Watchman businesses led the medtech company to cut its sales and earnings per share forecasts for the second quarter in a row.
FDA’s Labeling Resources for Human Prescription Drugs
Facing competition from Edwards, Abbott is studying TriClip’s real-world safety and performance in about 1,000 patients.
After keeping tight-lipped for nearly two years, Merck & Co. briefly dropped the first concrete hint as to where it intends to take its PD-1xVEGF bispecific antibody—before quietly scrubbing the evidence.
High-level turnover has introduced uncertainty about how quickly the FDA’s agency-wide AI strategy will move forward.
CMS’s new framework sounds like a gentle opt-in. There’s no requirement to meet every standard on day one, just a commitment to work toward doing the right thing. That sounds great. But to actually participate in the network, you have to meet a baseline level of interoperability. The post A New Era of Interoperability, But Who Gets Left Behind? appeared first on MedCity News .
The most common and most expensive misunderstanding in healthcare cloud strategy is treating the cloud as a destination you either reach or you do not, when it is really a progression through five distinct stages, each one unlocking capabilities the stage before it could not support. The post The Healthcare Cloud Maturity Model: The Five Stages Most Health Systems Skip appeared first on MedCity News .
In this week’s View, Dr. Eagle looks at a post-hoc analysis of the API-CAT trial that showed recurrent venous thromboembolism (VTE) is uncommon but associated with poor short-term survival of patients with cancer-associated thrombosis.
Patient group direction (PGD) template to support the national vaccination programme for pregnant women to protect infants and selected older adults as outlined in the RSV system letter.
Vaccine group direction (VGD) template to support the national vaccination programme for pregnant women to protect infants and selected older adults as outlined in the RSV system letter.
In June, NCQA brought together leaders from more than 50 healthcare organizations to discuss the future of credentialing. One theme emerged consistently throughout the discussion: the industry is ready to modernize credentialing processes while maintaining the trust, rigor and accountability that protect patients. “Credentialing is an important process to protect patient safety and prevent healthcare […] The post NCQA Credentialing Collaborative Explores the Future of Credentialing appeared first on NCQA .